Atara Biotherapeutics (ATRA) Earnings
|
Expand Research on ATRA
| Next EPS Date | 10/29/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -11.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/29/26  |
Q326 | N/A | -$0.14 | N/A | N/A | $1M | N/A | N/A | N/A | ||
| 8/12/26 | Q226 | -$0.32 | -$0.22 | -$0.10 | $630K | $2.55M | N/A |  | | Details | |
| 8/10/26 |
Q226 | N/A | -$0.22 | N/A | N/A | $2.55M | N/A | N/A | N/A | ||
| 5/12/26 | Q126 | -$0.29 | $0.00 | -$0.29 | $520K | N/A | N/A | | | Details | |
| 8/11/25 |
Q225 | N/A | -$0.27 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/11/25 | Q225 | $0.19 | $0.00 | +$0.19 | $17.58M | N/A | N/A | | | Details | |
| 5/15/25 | Q125 | $3.50 | $0.00 | +$3.50 | $98.15M | N/A | N/A | | | Details | |
| 8/12/24 | Q224 | -$3.10 | -$0.09 | -$3.01 | $28.64M | $37.09M | N/A | | | Details |
